103 related articles for article (PubMed ID: 20956280)
1. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma.
Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
Br J Ophthalmol; 2011 Jun; 95(6):853-8. PubMed ID: 20956280
[TBL] [Abstract][Full Text] [Related]
2. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
3. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
6. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
[TBL] [Abstract][Full Text] [Related]
7. Progesterone and estrogen receptors in conjunctival melanoma and nevi.
Bredow L; Stützel L; Böhringer D; Gundlach E; Reinhard T; Auw-Haedrich C
Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):359-65. PubMed ID: 24276560
[TBL] [Abstract][Full Text] [Related]
8. Expression of MCSP and PRAME in conjunctival melanoma.
Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Meller D; Zeschnigk M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
Br J Ophthalmol; 2010 Oct; 94(10):1322-7. PubMed ID: 20805128
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanoma.
Anastassiou G; Esser M; Bader E; Steuhl KP; Bornfeld N
Melanoma Res; 2004 Oct; 14(5):381-5. PubMed ID: 15457094
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of atypical conjunctival melanocytic nevi.
Jakobiec FA; Colby K; Bajart AM; Saragas SJ; Moulin A
Arch Ophthalmol; 2009 Aug; 127(8):970-80. PubMed ID: 19667333
[TBL] [Abstract][Full Text] [Related]
11. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
13. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
[TBL] [Abstract][Full Text] [Related]
14. Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome.
Slipicevic A; Holm R; Nguyen MT; Bøhler PJ; Davidson B; Flørenes VA
Am J Clin Pathol; 2005 Oct; 124(4):528-36. PubMed ID: 16146807
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
[TBL] [Abstract][Full Text] [Related]
16. PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.
Mikhail M; Velazquez E; Shapiro R; Berman R; Pavlick A; Sorhaindo L; Spira J; Mir C; Panageas KS; Polsky D; Osman I
Clin Cancer Res; 2005 Jul; 11(14):5153-7. PubMed ID: 16033830
[TBL] [Abstract][Full Text] [Related]
17. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
18. Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.
Song CH; Park SY; Eom KY; Kim JH; Kim SW; Kim JS; Kim IA
Breast Cancer Res; 2010; 12(2):R20. PubMed ID: 20226014
[TBL] [Abstract][Full Text] [Related]
19. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
